US Judge Rejects $2.36B Penalty Bid Against Google in Privacy Data Case 
Trump Threatens Aircraft Tariffs as U.S.-Canada Jet Certification Dispute Escalates 
Boeing Secures New Labor Contract With Former Spirit AeroSystems Employees 
Chinalco and Rio Tinto Acquire Controlling Stake in Brazil’s CBA for $903 Million 
Apple Faces Margin Pressure as Memory Chip Prices Surge Amid AI Boom 
Panama Supreme Court Voids CK Hutchison Port Concessions, Raising Geopolitical and Trade Concerns 
Bob Iger Plans Early Exit as Disney Board Prepares CEO Succession Vote 
Apple Forecasts Strong Revenue Growth as iPhone Demand Surges in China and India 
CSPC Pharma and AstraZeneca Forge Multibillion-Dollar Partnership to Develop Long-Acting Peptide Drugs 
SpaceX Reports $8 Billion Profit as IPO Plans and Starlink Growth Fuel Valuation Buzz 
Sandisk Stock Soars After Blowout Earnings and AI-Driven Outlook 
Meta Stock Surges After Q4 2025 Earnings Beat and Strong Q1 2026 Revenue Outlook Despite Higher Capex 
Amazon Stock Dips as Reports Link Company to Potential $50B OpenAI Investment 
Using the Economic Calendar to Reduce Surprise Driven Losses in Forex 
Climate Adaptation at Home: How Irrigreen Makes Conservation Effortless 
SpaceX Updates Starlink Privacy Policy to Allow AI Training as xAI Merger Talks and IPO Loom 
Nvidia Confirms Major OpenAI Investment Amid AI Funding Race 
PLEASANTON, Calif., May 30, 2017 -- Natus Medical Incorporated (NASDAQ:BABY) today announced that Jim Hawkins, President and Chief Executive Officer, will present at the Jefferies 2017 Healthcare Conference in New York City. Mr. Hawkins is scheduled to present at 8:00 a.m. EDT on Tuesday, June 6, 2017.
Investors may listen to a live webcast and view a copy of the slide presentation online via the "Investors" section of the Company's web site at http://investor.natus.com. The recorded webcast will be accessible online for at least 30 days.
About Natus Medical Incorporated
Natus is a leading provider of newborn care and neurology healthcare products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders.
Additional information about Natus Medical can be found at www.natus.com.
Natus Medical Incorporated Jonathan A. Kennedy Executive Vice President and Chief Financial Officer (925) 223-6700 [email protected]
